What is Psychotherapeutic Combinations ?

How the Drug Works:
Amitriptyline acts on the central nervous system (brain) to exert its antidepressant effects. Chlordiazepoxide acts on the central nervous system to effect emotional responses. Perphenazine acts on the central nervous system to exert its antipsychotic effects.
Precautions:
Neuroleptic Malignant Syndrome (NMS): (NMS)is a potentially fatal syndrome associated with perphenazine. Symptoms include increased body heat, muscle rigidity, altered mental abilities including catatonia (eg, confusion, withdrawal, unresponsivness), irregular pulse and blood pressure, increased heart rate, and sweating.
Tardive dyskinesia: Involuntary and uncontrollable movements may develop in patients treated with perphenazine. The likelihood that these symptoms will become permanent increases with long-term use and with high doses. However, it is possible to develop these symptoms after short-term treatment at low doses. Occurrence is highest among the elderly. The syndrome is characterized by rhythmical involuntary movements of the tongue, face, mouth, or jaw (eg, protrusion of tongue, puffing of cheeks, puckering of mouth, chewing movements), sometimes accompanied by involuntary movement of the arms and legs. Fine worm-like movements of the tongue may be an early sign of the syndrome. If the medication is stopped at this time, the syndrome may not develop. There is no known treatment for established cases of tardive dyskinesia, although the syndrome may stop, partially or completely, if the drug is withdrawn.
Pregnancy: Safety and effectiveness of psychotherapeutic combinations during pregnancy have not been established. Studies suggest an increased risk of congenital malformations associated with use of minor tranquilizers (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy. Use of these drugs during pregnancy should almost always be avoided. Use only if clearly needed and potential benefit to the mother outweigh the possible risk to the fetus.
Breastfeeding: It is not known whether these drugs are excreted in human milk. As a general rule, breastfeeding should not be undertaken while on these drugs, because many drugs are excreted in human milk. Consult your doctor before you begin breastfeeding.
Children: Safety and effectiveness of chlordiazepoxide and amitriptyline HCI in children younger than 12 years of age have not been established. Perphenazine and amitriptyline HCI combination is not recommended for use in children.
Elderly: Lowest effective dose is recommended to prevent in coordination, over sedation, confusion, or anticholinergic effects (eg, dry mouth, confusion, blurred vision, constipation, urinary retention).
Lab Tests: Lab tests or exams may be required during treatment with psychotherapeutic combinations. Tests may include periodic kidney and liver function tests and blood counts.
Drug Interactions:
Tell your doctor or pharmacist if you are taking or if you are planning to take any over-the-counter or prescription medications or dietary supplements with psychotherapeutic combinations. Doses of one or both drugs may need to be modified or a different drug may need to be pre­scribed. The following drugs and drug classes interact with psychotherapeutic combinations.

• Alcohol anticholinergics (eg, scopolamine) (perphenazine only)
• Anticoagulants (eg, dicumarol)
• Antifungal agents (eg, ketoconazole)
• Beta blockers (eg, propranolol) (chlordiazepoxide only)
• Carbamazepine (eg, Tegretol)
• Cimetidine (eg, Tagamet)
• Clonidine (eg, Catapres)
• CNS depressants (eg, barbiturates, narcotics)

Side Effects:
Every drug is capable of producing side effects. Many patients taking psychotherapeutic combinations experience no, or minor, side effects. The frequency and severity of side effects depend on many factors including dose, duration of therapy, and individual susceptibility. Possible side effects Include:
Withdrawal symptoms include convulsions , tremor , stomach and muscle cramps, vomiting, sweating.
Digestive Tract: Constipation; loss of appetite; bloating; nausea; stomach upset; vomiting; peculiar taste; diarrhea.
Nervous System: Drowsiness; dizziness; vivid dreams; confusion; tremor; fatigue; weakness; restlessness; lethargy; apprehension; poor concentration; delusions; hallucinations; in coordination; clumsiness; numb­ness; tingling and abnormal skin sensations of the arms and legs; fainting; headache.
Other: Dry mouth; impotence; nasal congestion; fast heartbeat; pounding in the chest; blurred vision; inability to urinate; rash; hives; increased sensitivity to light; itching; excessive or spontaneous flow of breast milk; menstrual irregularities; changes in blood sugar levels; increased sweating; frequent urination; dilated pupils; yellowing of the skin and eyes; hair loss; glandular swelling.
 
Guidelines for Use:

• Optimum dosage varies with the severity of the symptoms and the patient response. When satisfactory response is obtained, dosage should be reduced to the smallest amount needed to maintain satisfactory response.
• Chlordiazepoxide and amitriptyline – Initial dosage of 3 or 4 tablets daily in divided doses is recommended. The larger portion of the total daily dose may be taken at bedtime. In some patients, a single dose at bedtime may be sufficient.
• Perphenazine and amitriptyline – Usual initial dose is 3 to 4 tablets daily in divided doses. Lower inital doses may be used in adolescents and the elderly.
• Take only the amount prescribed by your doctor. Some of these medicines may be habit-forming and may produce dependence. Consult your doctor before increasing the dose or stopping the medicine.
• To avoid withdrawal symptoms after long-term use, a gradual dosage tapering schedule should be followed.
• Do not use in combination with MAOls or within 14 days of discontinuing treatment with an MAOI. After stopping these medicines, wait at least 14 days before starting an MAOI.
• Avoid alcohol and other mental depressants (eg, narcotics, tranquilizers, antihistamines) while you are taking psychotherapeutic combinations.

Neuropathy

The areas of the body most commonly affected by diabetic peripheral neuropathy are the feet and legs. Nerve damage in the feet can result in a loss of foot sensation, increasing your risk of foot problems. Injuries and sores on the feet may go unrecognized due to lack of sensation.

Causes of Neuropathy

The peripheral nerves relay information from your central nervous system (brain and spinal cord) to muscles and other organs and from your skin, joints, and other organs back to your brain.

Exposure to toxins, such as heavy metals, gold compounds, lead, arsenic, mercury, and organophosphate pesticides.

The peripheral nerves relay information from your central nervous system (brain and spinal cord) to muscles and other organs and from your skin, joints, and other organs back to your brain.

Autoimmune diseases, including lupus, rheumatoid arthritis or Guillain-Barre syndrome.

Multiple system atrophy, a degenerative disorder that leads to loss and malfunction of some portions of the central nervous system.

Alcoholism, a chronic, progressive disease that can lead to nerve damage.

What causes auditory neuropathy?

Although auditory neuropathy is not yet fully understood, scientists believe the condition probably has more than one cause. In some cases, it may involve damage to the inner hair cells–specialized sensory cells in the inner ear that transmit information about sounds through the nervous system to the brain.

Signs and Symptoms

Difficulty walking or moving the arms

Unusual sweating

oss of coordination and balance

Burning, freezing, or electric-like

The most common type of diabetic neuropathy, peripheral polyneuropathy affects nerves that transmit sensation, control muscle movement, and control bodily functions. Typically, symptoms start in the feet and spread up the legs.

If the autonomic nerves are damaged, involuntary functions may be affected. Symptoms that can result from this type of damage include abnormal blood pressure and heart rate, reduced ability to perspire, constipation, bladder dysfunction

Treatments of Neuropathy

Pain relievers. Mild symptoms may be relieved by over-the-counter pain medications. For more severe symptoms, your doctor may recommend prescription painkillers.

Medicines such as pain relievers or creams to relieve pain. Prescription medicines often used to reduce pain from diabetic neuropathy may include medicines that are more commonly used to treat depression.

The peripheral nerves provide communication between the brain and the organs, blood vessels, muscles, and skin.

Transcutaneous electrical nerve stimulation (TENS), which is a type of therapy that attempts to reduce pain by applying brief pulses of electricity to nerve endings in the skin.

Antidepressants. Tricyclic antidepressant medications, such as amitriptyline and nortriptyline (Pamelor), were originally developed to treat depression. However, they have been found to help relieve pain by interfering with chemical processes in your brain and spinal cord that cause you to feel pain.

What Are the Treatments for Peripheral Neuropathy?

Early diagnosis and treatment of peripheral neuropathy is important because the peripheral nerves have a limited capacity to regenerate, and treatment may only stop the progression, not reverse damage that is already present. If you have developed severe impairment, you may need physical therapy to help retain strength and avoid muscle cramping and spasms.

Is Botox Right For You?

Botulin toxin, sold commercially under the brand name Botox, is an exceptionally potent neurotoxin that has found a variety of remarkable uses in modern medicine. It is also the most popular nonsurgical medical cosmetic treatment in the UK and USA.

Researchers discovered in the 1950s that injecting overactive muscles with minute quantities of botulinum toxin type A decreased muscle activity by blocking the release of acetylcholine at the neuromuscular junction, thereby rendering the muscle unable to contract for a period of 4 to 6 months.

Alan Scott, a San Francisco ophthalmologist, first applied tiny doses of the toxin in a medicinal sense to treat crossed eyes and uncontrollable blinking, but a partner was needed to gain regulatory approval to market his discovery as a drug. Allergan, Inc., a small pharmaceutical company that focused on prescription eye therapies and contact lens products, bought the rights to the drug in 1988 and quickly received FDA approval in 1989. Allergan renamed the drug Botox.

Cosmetic benefits of Botox were quickly realized when the frown lines between the eyebrows appeared to soften following treatment for eye muscle disorders. The increased potential of Botox as a cosmetic treatment led to clinical trials and subsequent FDA approval in April 2002.

Currently, Botox is finding enormous additional potential in several therapeutic areas including the treatment of migraine headaches, cervical dystonia (a neuromuscular disorder involving the head and neck), blepharospasm (involuntary contraction of the eye muscles), and severe primary axillary hyperhidrosis (excessive sweating). Other uses of botulinum toxin type A that are widely known but not approved by FDA include urinary incontinence, anal fissure, spastic disorders associated with injury or disease of the central nervous system including trauma, stroke, multiple sclerosis, or cerebral palsy and focal dystonias affecting the limbs, face, jaw, or vocal cords. It is also used off label for the treatment of TMJ, but a side effect in some patients is a jaw left too weak to chew solid food for about 3 months after the injection.

Treatment and prevention of chronic headache and chronic musculoskeletal pain are emerging uses for botulinum toxin type A. In addition, there is evidence that Botox may aid in weight loss by increasing the gastric emptying time.

As an alternative to Botox, anti-aging creams are heavily marketed and advertised on television, with the promise of looking younger and the reduction in visible wrinkles on the skin.

Traditionally, they have been targeted towards women, but products specifically targeting men are now common. This change may be due to the fact that many societies in recent years have seen an increased focus on young looks, including in men. Some men report that looking younger makes it easier to get a good job.

There are a range of cosmetic ‘treatments’ for the appearance of wrinkles on the skin such as plastic surgery and botox injections. One of the marketed advantages of anti-aging cream is that it is an alternative to these more extreme cosmetic treatments.

Critics take the view that the manufacturers of these products prey on the fears of women, and that the advertisements abuse science by claiming that their products are scientifically proven to work. It is said that the ’scientific data’ is based on the perception of women who have tried the product, and are asked whether or not they think they look younger. These are the hallmarks of a placebo.

However, it is plausible that some of the anti-aging products could have a rejuvenating effect, as promised. However, the effects of most anti-aging products likely depends on their concentration and mode of application, making their effects less certain.

Permission is granted to reprint this article as long as no changes are made, and the entire resource box is included.

About Excessive Sweating And Ho To Stop It